Vol 13, No 7 (July 31, 2024): Translational Cancer Research

Original Article

Development and validation of a glioma prognostic model based on telomere-related genes and immune infiltration analysis
Xiaozhuo Liu, Jingjing Wang, Dongpo Su, Qing Wang, Mei Li, Zhengyao Zuo, Qian Han, Xin Li, Fameng Zhen, Mingming Fan, Tong Chen
Translational Cancer Research  
2024;
13
(7)
:3182-3199
.
Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer
Wanting Zheng, Wangjianfei Yu, Ruheng Hua, Jun He, Nuwa Wu, Siyun Tian, Wentao Huang, Lei Qin
Translational Cancer Research  
2024;
13
(7)
:3200-3216
.
Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma
Jing Yong, Dongdong Wang, Huiming Yu
Translational Cancer Research  
2024;
13
(7)
:3217-3241
.
Prognostic factors and treatment strategies of limited-stage primary esophageal small-cell carcinoma—a SEER database analysis
Yang Yang, Haizhou Guo, Qianping Li, Weipeng Huang
Translational Cancer Research  
2024;
13
(7)
:3242-3250
.
Effect and mechanism of curcumin on colon cancer cell senescence through early growth response 1 (EGR1)
Dan Xu, Linjun Li, Zhaomin Yu
Translational Cancer Research  
2024;
13
(7)
:3251-3261
.
LncRNA CBR3-AS1 is associated with the BCR::ABL1 kinase independent mechanism of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia patients
Wuqiang Lin, Xiuli Chen, Heyong Zheng, Zhenjie Cai, Linjun Xie, Beibei Zhang, Rongrong Zheng
Translational Cancer Research  
2024;
13
(7)
:3262-3272
.
Tumor hypoxia in immune infiltration and prognosis of bladder cancer
Fanghong Xu, Xinyue Yao, Nanjing Zhou, Zuohuai Hu, Chenrui Guo, Hang Zhou, Xiaokai Yan
Translational Cancer Research  
2024;
13
(7)
:3273-3284
.
A novel m6A/m5C/m1A/m7G‐related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer
Ruyue Chen, Lixin Jiang
Translational Cancer Research  
2024;
13
(7)
:3285-3298
.
Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer
Yirong Lin, Zuming Xiong, Yongjun Yang, Wenxin Li, Wei Huang, Minglin Lin, Sen Zhang
Translational Cancer Research  
2024;
13
(7)
:3299-3317
.
Treatments and prognostic outcomes of combined hepatocellular-cholangiocarcinoma with distant metastasis: an analysis based on SEER data
Leilei Zhang, Yunxi Lu, Yuting Chen, Xiangling Lu, Xiaoli Lao
Translational Cancer Research  
2024;
13
(7)
:3318-3327
.
Correlation between initial alkaline phosphatase levels and overall survival in newly diagnosed multiple myeloma patients
Jie Tan, Jun-Peng Liu, Xing-Chen Yao, Zi-Yu Xu, Yue Wu, Xiang-Jun Shi, Ming Shi, Meng Li, Xin-Ru Du
Translational Cancer Research  
2024;
13
(7)
:3328-3337
.
Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma
Yongsheng Liu, Lize Cai, Hao Wang, Lin Yao, Kai Zhang, Guangliang Chen, Youxin Zhou
Translational Cancer Research  
2024;
13
(7)
:3338-3353
.
Comprehensive analysis to identify the relationship between CALD1 and immune infiltration in glioma
Jing Xia, Qiuan Yang, Chengwei Wang, Zhenwei Sun
Translational Cancer Research  
2024;
13
(7)
:3354-3369
.
Comparison of Cox regression and generalized Cox regression models to machine learning in predicting survival of children with diffuse large B-cell lymphoma
Jia-Jia Qin, Xiao-Xiao Zhu, Xi Chen, Wei Sang, Ying-Liang Jin
Translational Cancer Research  
2024;
13
(7)
:3370-3381
.
Identification and validation of ferroptosis-related prognostic gene signature in patients with cervical cancer
Xiao-Feng Ruan, Dan-Ting Wen, Zheng Xu, Ting-Ting Du, Zhao-Feng Fan, Fang-Fang Zhu, Jing Xiao
Translational Cancer Research  
2024;
13
(7)
:3382-3396
.
MiR-1271-5p promotes the growth and migration of neuroblastoma cells by regulating ACY-1
Jun Sun, Xiaowen Zhang, Zimin Chen, Xiaoshuo Ye, Chen Zhang
Translational Cancer Research  
2024;
13
(7)
:3397-3406
.
SCG2 and CPE may be novel markers for the identification of pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms
Wuhan Yang, Shubin Wang, Zhilei Zhang, Hao Guo, Chengyu Liu, Meng Zhao, Yueping Liu, Li Peng
Translational Cancer Research  
2024;
13
(7)
:3407-3417
.
Identification of a cancer driver gene-associated lncRNA signature for prognostic prediction and immune response evaluation in clear cell renal cell carcinoma
Juncheng Pan, Daorong Hu, Xiaolong Huang, Jie Li, Sizhou Zhang, Jiabing Li
Translational Cancer Research  
2024;
13
(7)
:3418-3436
.
Short-term outcomes of three- and two-field lymphadenectomy with minimally invasive esophagectomy for esophageal cancer: a propensity score-matching analysis
Zeng-Feng Sun, Bo-Shi Fan, Jun-Qiang Liu, Shou-Yin Di, Cai-Ying Yue, Jia-Hua Zhao, Ju-Si Wang, Wei-An Song, Jing Lu, Jia-Le Zhang, Tai-Qian Gong
Translational Cancer Research  
2024;
13
(7)
:3437-3445
.
SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance
Zhe Sun, Zhiyan Nie, Yao Xu, Yingshun Cui, Wenjian Ma, Tongcun Zhang
Translational Cancer Research  
2024;
13
(7)
:3446-3464
.
The roles of lncRNA AP001469.3 in clinical implications, immune landscape and carcinogenesis of colorectal cancer
Tao Chen, Qiusheng Jiang, Zhenlin Wang, Hongqiang Zhang, Zan Fu
Translational Cancer Research  
2024;
13
(7)
:3465-3481
.
Survival and analysis of prognostic factors for fibroblastic osteosarcoma patients: a population-based study
Dongsheng Zhu, Wen Zheng, Han Qi, Feng Chen, Xiaodong Wang
Translational Cancer Research  
2024;
13
(7)
:3482-3494
.
Telomere-related gene risk model for prognosis prediction in colorectal cancer
Hao Chen, Yuhao Pan, Chenhui Lv, Wei He, Dingting Wu, Qijia Xuan
Translational Cancer Research  
2024;
13
(7)
:3495-3521
.
The ratio of PKM1/PKM2 is the key factor affecting the glucose metabolism and biological function of colorectal cancer cells
Liang Ma, Xue Zhang, Yan Liu, Hui Jin, Dan Li, Hui Zhang, Li Feng, Jing Zuo, Yudong Wang, Jiayin Liu, Jing Han
Translational Cancer Research  
2024;
13
(7)
:3522-3535
.
SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma
Kaihong Wang, Xinpeng Chen, Yifu Liu, Xuan Meng, Libo Zhou
Translational Cancer Research  
2024;
13
(7)
:3536-3555
.
Stratifying osteosarcoma patients using an epigenetic modification-related prognostic signature: implications for immunotherapy and chemotherapy selection
Zhichao Li, Yong Xue, Xianxing Huang, Gang Xiao
Translational Cancer Research  
2024;
13
(7)
:3556-3574
.
Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer
Zhipeng Xu, Xu Xu, Jianpeng Hu, Jian Tan, Yuanye Wan, Feilun Cui
Translational Cancer Research  
2024;
13
(7)
:3575-3588
.
Monocytes-to-lymphocytes ratio increases the prognostic value of circulating tumor cells in non-small cell lung cancer: a prospective study
Yun Huangfu, Fangfang Chang, Fengjuan Zhang, Yanru Jiao, Lei Han
Translational Cancer Research  
2024;
13
(7)
:3589-3598
.
Bioinformatics reveals the potential mechanisms and biomarkers of necroptosis in neuroblastoma
Bing Gao, Shaochun Yan, Wei Xie, Guo Shao
Translational Cancer Research  
2024;
13
(7)
:3599-3619
.
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy
Haiyong Jin, Lei Zheng, Jie Wang, Bo Zheng
Translational Cancer Research  
2024;
13
(7)
:3620-3636
.
Clinical characteristics and prognosis of liver metastases with unknown primary site
Fuli Gao, Luojie Liu, Xiaodan Xu
Translational Cancer Research  
2024;
13
(7)
:3637-3651
.
Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer
Huanhuan Hu, Shenglong Yuan, Yuqi Fu, Huixin Li, Shuyue Xiao, Zhen Gong, Shanliang Zhong
Translational Cancer Research  
2024;
13
(7)
:3652-3667
.
Expression profiles of serum transfer RNA-derived fragments and their potential roles in non-small cell lung cancer
Yulan Song, Jipeng Li
Translational Cancer Research  
2024;
13
(7)
:3668-3677
.
Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma
Xijin Lin, Kongfeng Shao, Zhuangbin Lin, Qiandong Liang, Xiaoyan Li, Haiyan Chen, Junxin Wu
Translational Cancer Research  
2024;
13
(7)
:3678-3694
.
CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells
Sung Hee Lim, Song-Yi Lee, Jung Yong Hong, Jeeyun Lee, Seung Tae Kim
Translational Cancer Research  
2024;
13
(7)
:3695-3703
.
Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model
Shengmei Liang, Xinze Qiu, Lulu Cai, Fangyou Wei, Jiean Huang, Shiquan Liu
Translational Cancer Research  
2024;
13
(7)
:3704-3717
.
A retrospective study of anlotinib in patients with persistent, recurrent or metastatic cervical and endometrial cancer
Lingli Xin, Mei Ye, Yuan Gao, Qi Xiong, Qingxiang Hou
Translational Cancer Research  
2024;
13
(7)
:3718-3728
.
TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling
Ting He, Borui Xu, Haiqing Ma
Translational Cancer Research  
2024;
13
(7)
:3729-3741
.
Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma
Honglin Wu, Chuanbao Deng, Xiaoqing Zheng, Yongxiong Huang, Chong Chen, Honglin Gu
Translational Cancer Research  
2024;
13
(7)
:3742-3759
.
Identification and validation of endoplasmic reticulum stress-related genes that enhance immunotherapy in colon cancer
Baolin Wang, Jun Yang, Jiexin Wu, Xiaoming Hu, Jun Zhu, Jiang Fang, Bo Han, Bo Zhou
Translational Cancer Research  
2024;
13
(7)
:3760-3770
.
Identification of hub genes and key modules in laryngeal squamous cell carcinoma
Hongyue Li, Shaojun Bo, Yutian Guo, Tiantian Wang, Yangwang Pan
Translational Cancer Research  
2024;
13
(7)
:3771-3782
.
Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
Jing-Jing Zhang, Yu-Lan Qian, Zi-Yang Wu, Yue Li, Ying-Jie Guan, Cui Sun, Kai-Li Fu, Tong-Lin Mei, Gaurav Goyal, Paolo Bernasconi, Daniela Damiani, Jian-Guo Zhu
Translational Cancer Research  
2024;
13
(7)
:3783-3797
.
Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula’s mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation
Yunzhen Wang, Guijuan He, Mire Zloh, Tao Shen, Zhengfu He
Translational Cancer Research  
2024;
13
(7)
:3798-3813
.
Exploring the effects of matrix metalloproteinase-13 on the malignant biological behavior of tongue squamous cell carcinoma via the TNF signaling pathway based on bioinformatics methods
Junqin Lu, Yeqian Zhu, Jie Zhang, Ningning Cao
Translational Cancer Research  
2024;
13
(7)
:3814-3825
.
Identifying key pathogenic mechanisms and potential intervention targets for recurrence after laryngeal cancer treatment through bioinformatics screening
Laiyan Liu, Jiebin Wu
Translational Cancer Research  
2024;
13
(7)
:3826-3841
.
The mechanism of Taohong Siwu decoction in treating chemotherapy-induced peripheral neuropathy: a network pharmacology and molecular docking study
Meiyu Zhou, Li Liu, Yonghong Tan, Rui Huang, Zailiang Yang
Translational Cancer Research  
2024;
13
(7)
:3842-3853
.

Review Article

The role of dysregulated metabolism and associated genes in gastric cancer initiation and development
Zhengyan Jiang, Zhengrong Gu, Xianyan Lu, Wei Wen
Translational Cancer Research  
2024;
13
(7)
:3854-3868
.
Research progress on factors affecting the sensitivity of breast cancer to radiotherapy: a narrative review
Qian Zhang, Fusheng Qian, Mengjie Cai, Ruijie Liu, Manping Chen, Zhitong Li, Ying Chen, Nannan Lu
Translational Cancer Research  
2024;
13
(7)
:3869-3888
.
Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review
Keita Nakane, Makoto Kawase, Daiki Kato, Koji Iinuma, Kota Kawase, Shinichi Takeuchi, Yuki Tobisawa, Takayasu Ito, Takuya Koie
Translational Cancer Research  
2024;
13
(7)
:3889-3897
.
The role of immune metabolism in skin cancers: implications for pathogenesis and therapy
Xuanyu Lu, Yurui Zhu, Tianyu Qin, Yu Shen
Translational Cancer Research  
2024;
13
(7)
:3898-3903
.
Clinical research progress of telomerase targeted cancer immunotherapy: a literature review
Yu Wang, Xiaoying Zhang, Guangming Chen, Mingzhe Shao
Translational Cancer Research  
2024;
13
(7)
:3904-3921
.

Case Report

Brain stem angioleiomyoma mimicking meningioma: a case report
Hailiang Tang, Wendi Hua, Ying Wang, Ji Xiong, Haixia Cheng, Ming Xu, Jian Xu, Ping Zhong
Translational Cancer Research  
2024;
13
(7)
:3922-3927
.

Retraction

Retraction: involvement of DNA methyltransferase 1 (DNMT1) and multidrug resistance-associated proteins in 2-methoxyestradiol-induced cytotoxicity in EC109/Taxol cells
Qingqing Yang, Xiaojing Guo, Yue Xu, Chang Duan, Haofan Wang, Quanling Feng, Nan Zhang
Translational Cancer Research  
2024;
13
(7)
:3928
.